Medication Talk

Cardiovascular Impact of Diabetes Meds


Listen Later

Listen in as our expert panel discusses which diabetes meds have cardiovascular (CV) benefits.  We’ll review the evidence and discuss the pros and cons of SGLT2 inhibitors (dapagliflozin, empagliflozin, etc) and GLP-1 agonists (dulaglutide, semaglutide, etc) in patients with or at risk for CV disease.

Special Guests:

  • Lauren G. Pamulapati, PharmD, BCACP
    • Associate Professor, Ambulatory Care
    • Virginia Commonwealth University School of Pharmacy
    • Clinical Pharmacist, Hayes Willis Health Center/VCU Health
  • Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP
    • Professor, Pharmacy Practice
    • Director, PGY2 Ambulatory Care Residency Program
    • Midwestern University College of Pharmacy, Downers Grove Campus
    • Clinical Pharmacist, Northwestern Medicine

TRC Editorial Advisory Board Participant:

  • Stephen Carek, MD, CAQSM, DipABLM
    • Clinical Associate Professor of Family Medicine
    • Prisma Health/USC-SOMG Family Medicine Residency Program
    • USC School of Medicine Greenville

For the purposes of disclosure, Dr. Schumacher reports a relevant financial relationship [CGM for diabetes management] with Abbott (speakers bureau).

The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in February 2025.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights

  • Chart: Diabetes Medications: Cardiovascular and Kidney Impact
  • Chart: Drugs for Type 2 Diabetes 
  • Algorithm: Stepwise Treatment of Type 2 Diabetes
  • Chart: Comparison of GLP-1 Agonists
  • Toolbox: Improving Heart Failure Care

Send a text

Email us: [email protected].

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.

...more
View all episodesView all episodes
Download on the App Store

Medication TalkBy TRC Healthcare

  • 4.3
  • 4.3
  • 4.3
  • 4.3
  • 4.3

4.3

47 ratings


More shows like Medication Talk

View all
JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

504 Listeners

Diabetes Core Update by American Diabetes Association

Diabetes Core Update

103 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,381 Listeners

Real Life Pharmacology - Pharmacology Education for Health Care Professionals by Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist

Real Life Pharmacology - Pharmacology Education for Health Care Professionals

728 Listeners

The Peter Attia Drive by Peter Attia, MD

The Peter Attia Drive

8,018 Listeners

Psychopharmacology and Psychiatry Updates by Psychopharmacology Institute

Psychopharmacology and Psychiatry Updates

297 Listeners

JAMA Medical News by JAMA Network

JAMA Medical News

89 Listeners

All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks & Friedberg

10,181 Listeners

The Curious Clinicians by The Curious Clinicians

The Curious Clinicians

378 Listeners

Huberman Lab by Scicomm Media

Huberman Lab

29,276 Listeners

followHIM by Hank Smith & John Bytheway

followHIM

10,971 Listeners

Medication Talk by TRC Healthcare

Medication Talk

37 Listeners

The Mel Robbins Podcast by Mel Robbins

The Mel Robbins Podcast

20,577 Listeners

Clinical Capsules by TRC Healthcare

Clinical Capsules

3 Listeners

Rumor vs Truth by TRC Healthcare

Rumor vs Truth

6 Listeners